Wilson Sonsini Goodrich & Rosati advised Assembly Bio on the transaction, and Ropes & Gray advised Gilead Sciences, Inc. Assembly Biosciences (Nasdaq: ASMB) and Gilead Sciences (Nasdaq:...
Assembly Biosciences’ Partnership with Gilead Sciences
Carlin Consumer Health’s Acquisition of Infirst USA Holdings
Sidley Austin LLP served as legal advisor to Carlin and Wilson Sonsini Goodrich Rosati acted as legal advisor to Infirst. Stifel acted as exclusive financial advisor...
Nexu’s $20 Million Series B Financing Round
Wilson Sonsini Goodrich & Rosati advised Valor Capital on the transaction. Nexu announced it has raised $20 million in a Series B funding. The round was led...
Tofu’s $5 Million Seed Financing Round
Wilson Sonsini Goodrich & Rosati advised Tofu on the transaction. Tofu announced that it raised $5 million in seed funding. The round was led by Index Ventures...
Plutonian Acquisition Corp.’s $500 Million Business Combination with Big Tree Cloud
Wilson Sonsini Goodrich & Rosati and Global Law Office represented Plutonian in the transaction, Paul Hastings LLP, Commerce & Finance Law Offices and Maples Group represented...
Denodo’s $336 Million Series B Financing
Wilson Sonsini Goodrich & Rosati advised Denodo on the transaction. Denodo announced that they have signed a definitive agreement for TPG Growth (NASDAQ:TPG), the firm’s middle...
BioMap’s Collaboration with Sanofi
Wilson Sonsini Goodrich & Rosati advised BioMap on the transaction. BioMap announced a collaboration with Sanofi, to co-develop advanced AI modules for biotherapeutic drug discovery leveraging BioMap’s...
Castelion’s $14.2 Million Seed Funding Round
Wilson Sonsini Goodrich & Rosati advised Andreessen Horowitz (a16z) on the transaction. Castelion announced it raised $14.2 million Series Seed funding round co-led by Andreessen Horowitz (a16z)...
ALX Oncology’s $63 Million Common Stock Offering
Wilson Sonsini Goodrich & Rosati advised ALX Oncology Holdings Inc. on the offering, and Cooley advised the underwriters. ALX Oncology Holdings Inc. (Nasdaq:ALXO) announced the pricing...
Soleno Therapeutics’ $120 Million Common Stock Offering and Private Placement
Wilson Sonsini Goodrich & Rosati and Cooley advised Soleno Therapeutics on the deal. Soleno Therapeutics, Inc. (Nasdaq:SLNO), (“Soleno”) announced the pricing of the underwritten public offering of...
Endoxa’s Launch of Position Reporting Utility
Wilson Sonsini Goodrich & Rosati represented Droit in the transaction. Endoxa announced the collaboration of its five leading financial institutions including Barclays, BNP Paribas, Goldman Sachs, and...
Plenful’s $9 Million Seed Round
Wilson Sonsini Goodrich & Rosati advised Plenful on the transaction. Plenful announced $9 million in funding led by Bessemer Venture Partners and more than 20 enterprise customers...